phrykt

Cardlytics, Inc. (CDLX): who owns it and who trades it

As of Nov 16, 2026, CDLX insiders reported 16 open-market sales worth $535K and 2 purchases worth $129K in the last 12 months, with 0% of the sale value made under pre-set 10b5-1 plans. The largest seller was Amit Gupta (CEO), with $469K. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Cardlytics

From the latest filings

Overall: more selling than buying. Insiders and famous investors mostly sold.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, CDLX insiders reported $129K of open-market purchases and $535K of sales. 0% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$129K
2 trades, 1 people
Sales, 12 months
$535K
16 trades, 3 people
Sales under a 10b5-1 plan
0%
Share of sale value
Latest trade
Oct 2, 2026
Filed Oct 2, 2026

Purchases and sales by month

$241K$241KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Oct 2, 2026Amit GuptaCEOSale7,382$2.53$18.7KForm 4
Oct 1, 2026Amit GuptaCEOSale10,351$2.71$28.1KForm 4
Aug 18, 2026Amit GuptaCEOSale6,676$4.03$26.9KForm 4
Aug 17, 2026Amit GuptaCEOSale6,785$3.97$26.9KForm 4
Jul 6, 2026Amit GuptaCEOSale9,640$4.39$42.3KForm 4
Jul 2, 2026Amit GuptaCEOSale6,498$4.40$28.6KForm 4
Jul 2, 2026Nicholas Hollmeyer LyntonChief Legal & Privacy OfSale2,151$4.40$9.5KForm 4
May 18, 2026David Thomas EvansCFOPurchase50,000$0.63$31.5KForm 4
May 15, 2026David Thomas EvansCFOPurchase150,000$0.65$97.5KForm 4
Apr 6, 2026Amit GuptaCEOSale69,833$1.19$83.1KForm 4
Apr 2, 2026Amit GuptaCEOSale54,225$1.04$56.4KForm 4
Apr 1, 2026Amit GuptaCEOSale62,549$0.99$61.9KForm 4
Apr 1, 2026Nicholas Hollmeyer LyntonChief Legal & Privacy OfSale40,296$0.99$39.9KForm 4
Feb 18, 2026Amit GuptaCEOSale45,159$0.93$42KForm 4
Feb 17, 2026Amit GuptaCEOSale52,049$0.90$46.8KForm 4
Jan 5, 2026Nicholas Hollmeyer LyntonChief Legal & Privacy OfSale6,253$1.17$7.3KForm 4
Jan 5, 2026Amit GuptaCEOSale5,807$1.17$6.8KForm 4
Jan 5, 2026Alexis DeSienoCFOSale8,607$1.17$10.1KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Amit GuptaChief Executive Officer, Director–$469KOct 2, 2026
David Thomas EvansChief Financial Officer$129K–May 18, 2026
Nicholas Hollmeyer LyntonChief Legal & Privacy Officer–$56.7KJul 2, 2026
Alexis DeSienoChief Financial Officer–$10.1KJan 5, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CDLX short interest

Moderate short interest. 8.1% of CDLX shares are sold short: about 1 share in 12. Over the last 12 reports the number of shares short went down 38%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 475,225 CDLX shares were sold short, 8.1% of the shares outstanding, down 4.6% from the report before. At the average daily volume of 83,719 shares, buying them all back would take about 5.7 trading days (days to cover).

Shares short, % of all shares

8.07%May 15Oct 3015.0%

Days to cover

5.7May 15Oct 3023.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026475,2258.07%-5%83,7195.7
Oct 15, 2026498,3258.46%-16%92,1185.4
Sep 30, 2026594,06010.09%-9%28,51320.8
Sep 15, 2026651,98211.07%+3%44,53514.6
Aug 31, 2026630,93910.71%+3%42,17815.0
Aug 14, 2026613,22110.41%-5%49,66512.3
Jul 31, 2026645,15610.96%-3%40,35316.0
Jul 15, 2026663,293–-3%63,15810.5
Jun 30, 202668,6351.19%-6%60,58111.3
Jun 15, 202672,8101.26%-90%121,4796.0
May 29, 2026756,10513.13%-1%634,72511.9
May 15, 2026762,22913.23%-13%1.07M7.1

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Cardlytics company events

Cardlytics filed 12 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership, listing). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Sep 11, 2026AgreementAs previously disclosed in the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, in connection with the acquisition of Bridg, Inc. by Cardlytics, Inc. in 2021, the Company assumed certain indemnification obligations to former officers and directors of Bridg… Filing
  3. Aug 5, 2026ResultsReleased financial results. Filing
  4. Jun 3, 2026ListingCardlytics, Inc., a Delaware corporation, received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC notifying the Company that for the last 30 consecutive business days, the bid price of the Company’s common stock had closed below $1.00 per share, the minimum closing… Filing
  5. May 20, 2026VoteReported shareholder vote results. Filing
  6. May 12, 2026LeadershipNick Lynton, Chief Legal and Privacy Officer of Cardlytics, Inc., notified the Company of his intent to resign from such position, effective as of the earlier of the appointment of his successor or the close of business on July 3, 2026. Filing
  7. May 7, 2026ResultsReleased financial results. Filing
  8. Mar 24, 2026DealCOMPLETION OF ACQUISITION OF DISPOSITION OF ASSETS As previously disclosed by Cardlytics, Inc. on a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on January 26, 2026, on January 23, 2026, the Company, PAR Technology Corporation and DB Sub, LLC, an indirectly… Filing
  9. Mar 4, 2026ResultsReleased financial results. Filing
  10. Jan 26, 2026AgreementCardlytics, Inc., PAR Technology Corporation and DB Sub, LLC, an indirectly wholly owned subsidiary of PAR, entered into an asset purchase agreement, pursuant to which Buyer agreed to acquire all of the Company’s assets, properties and rights primarily related to, or primarily used in, its Bridg… Filing
  11. Dec 18, 2025LeadershipCardlytics, Inc. announced the appointment of David Evans as the Company’s Chief Financial Officer, principal financial officer and principal accounting officer, effective as of January 12, 2026. Filing
  12. Dec 5, 2025LeadershipAlexis DeSieno, the Company’s Chief Financial Officer, notified the Company of her intent to resign as Chief Financial Officer, effective as of the earlier of the appointment of her successor or the close of business on March 6, 2026. Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Cardlytics financials

Famous investors that hold CDLX

2 of the 50 well-known investors we track reported holding CDLX in their latest 13F filing. The largest position is Ken Griffin's, worth $56.8K.

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 202619,325$56.8K0.0%-32%
Jim Simons · Renaissance TechnologiesQ3 202618,405$54.1K0.0%No change

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Cardlytics, Inc. (CDLX) stock

Are CDLX insiders buying or selling?

In the last 12 months, CDLX insiders reported 2 open-market purchases worth $129K and 16 sales worth $535K. The latest trade was on Oct 2, 2026. See every trade.

What is the short interest in CDLX?

As of Oct 30, 2026, 475,225 CDLX shares were sold short, 8.1% of the shares outstanding, down 4.6% from the report before. At the average daily volume of 83,719 shares, buying them all back would take about 5.7 trading days (days to cover). See the history.

Which famous investors hold CDLX?

2 of the 50 well-known investors we track reported CDLX in their latest 13F filing, including Ken Griffin, Jim Simons. The largest position is worth $56.8K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.